[Federal Register Volume 79, Number 133 (Friday, July 11, 2014)]
[Notices]
[Pages 40113-40114]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-16207]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2014-N-0894]
2014 Scientific Meeting of the National Antimicrobial Resistance
Monitoring System; Public Meeting; Request for Comments
AGENCY: Food and Drug Administration, HHS.
[[Page 40114]]
ACTION: Notice of public meeting; request for comments.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing a public
meeting entitled ``2014 Scientific Meeting of the National
Antimicrobial Resistance Monitoring System.'' The purpose of the
meeting is to discuss progress made in achieving the goals of the
National Antimicrobial Resistance Monitoring System (NARMS) Strategic
Plan: 2012-2016.
Dates And Time: The public meeting will be held on August 12 and
13, 2014, from 8 a.m. to 5 p.m.
ADDRESSES: Location: The public meeting will be held at the FDA White
Oak Campus, 10903 New Hampshire Ave., Building 31, Great Room (rm.
1503A), Silver Spring, MD 20993-0002. Please note that visitors to the
White Oak Campus must enter through Building 1. The White Oak Campus
location is a Federal facility with security procedures. For parking
and security information, please refer to http://www.fda.gov/AboutFDA/WorkingatFDA/BuildingsandFacilities/WhiteOakCampusInformation/ucm241740.htm.
FOR FURTHER INFORMATION CONTACT: Laura Bradbard, Center for Veterinary
Medicine (HFV-12), Food and Drug Administration, 7519 Standish Pl.,
Rockville, MD 20855, 240-276-9109, FAX: 240-276-9115,
[email protected].
SUPPLEMENTARY INFORMATION: NARMS periodically conducts public meetings
to inform stakeholders of NARMS activities and receive comments on ways
to improve. The last two public NARMS meetings (held in 2010 and 2011)
focused on recommendations made by the FDA Science Board Advisory
Subcommittee in 2007. These meetings dealt with enhancing international
partnerships, and improving NARMS sampling. Since then, NARMS created
the 2012-2016 Strategic Plan that addressed all of the Science Board's
recommendations (http://www.fda.gov/downloads/AnimalVeterinary/SafetyHealth/AntimicrobialResistance/NationalAntimicrobialResistanceMonitoringSystem/UCM236283.pdf). A
number of strategic planning goals already have been achieved and
several of the objectives outlined in the plan are ongoing. The purpose
of this meeting will be to provide updates on progress of the NARMS
2012-2016 strategic plan, discuss possible future activities, and
receive comments for the official record. A number of items will be
discussed including comparisons of new and old slaughter sampling
methods, the role of NARMS in foodborne outbreaks, results of
interagency research projects using advanced detection methods, and how
these scientific advances impact FDA decisionmaking.
Registration and Requests for Oral Presentations: Interested
persons may make oral presentations on the topic of the discussion of
the meeting. Oral presentations from the public during the open public
comment period will be scheduled between approximately 3:50 p.m. and
4:50 p.m. on August 13, 2014. Those desiring to make oral presentations
should notify the contact person by July 29, 2014, and submit a brief
statement of the general nature of information they wish to present. In
an effort to accommodate all who desire to speak, time allotted for
each presentation may be limited. The contact person will inform each
speaker of their schedule prior to the meeting.
Registration is required for the meeting. Please send registration
information (including name, title, organization, address, and
telephone and fax numbers) by email to Laura Bradbard (see FOR FURTHER
INFORMATION CONTACT) by July 29, 2014. There is no fee to register for
the public meeting, and registration will be on a first-come, first-
served basis.
If you need special accommodations due to a disability, please
contact Laura Bradbard (see FOR FURTHER INFORMATION CONTACT) at least 7
days in advance.
Comments: Regardless of attendance at the public meeting,
interested persons may submit either electronic or written comments
regarding the topic to be discussed at the meeting. Submit electronic
comments to http://www.regulations.gov. Submit written comments to the
Division of Dockets Management (HFA-305), Food and Drug Administration,
5630 Fishers Lane, rm. 1061, Rockville, MD 20852. It is only necessary
to send one set of comments. Identify comments with the docket number
found in brackets in the heading of this document. Received comments
may be seen in the Division of Dockets Management between 9 a.m. and 4
p.m., Monday through Friday. The docket will remain open for written or
electronic comments for 30 days following the meeting.
Agenda: The meeting will address monitoring and research for NARMS.
The final agenda for the public meeting will be made available on the
Agency's Web site at http://www.fda.gov/AnimalVeterinary/SafetyHealth/AntimicrobialResistance/NationalAntimicrobialResistanceMonitoringSystem/ucm059135.htm and will
be posted to the docket athttp://www.regulations.gov no later than 2
weeks prior to the meeting.
Transcripts: FDA will prepare a meeting transcript and make it
available on the Agency's Web site (see Agenda) after the meeting. FDA
anticipates that transcripts will be available approximately 60
business days after the meeting. The transcript will be available for
public examination at the Division of Dockets Management (HFA-305),
Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville,
MD 20852, between 9 a.m. and 4 p.m., Monday through Friday. A
transcript will also be available in either hardcopy or on CD-ROM after
submission of a Freedom of Information request. Written requests are to
be sent to Division of Freedom of Information (ELEM-1029), Food and
Drug Administration, 12420 Parklawn Dr., Element Bldg., Rockville, MD
20857.
Dated: July 7, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-16207 Filed 7-10-14; 8:45 am]
BILLING CODE 4164-01-P